Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Boston Scientific Corp (BSX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 37,412,008
  • Shares Outstanding, K 1,369,400
  • Annual Sales, $ 8,386 M
  • Annual Income, $ 347,000 K
  • 36-Month Beta 1.10
  • Price/Sales 4.45
  • Price/Cash Flow 15.73
  • Price/Book 5.29

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.79 +5.93%
on 04/27/17
27.52 -0.73%
on 05/26/17
+1.35 (+5.20%)
since 04/26/17
3-Month
24.02 +13.74%
on 03/22/17
27.52 -0.73%
on 05/26/17
+2.54 (+10.25%)
since 02/24/17
52-Week
19.67 +38.89%
on 12/01/16
27.52 -0.73%
on 05/26/17
+4.76 (+21.10%)
since 05/26/16

Most Recent Stories

More News
Boston Scientific (BSX) BT Study on Asthma Results Positive

Boston Scientific Corporation (BSX) recently unveiled positive outcome from the Post Approval Clinical Trial Evaluating Bronchial Thermoplasty (BT) in Severe Persistent Asthma (PAS2) study.

EW : 114.25 (+0.07%)
BSX : 27.32 (+0.22%)
LMNX : 20.41 (-0.05%)
INGN : 87.93 (-1.15%)
Boston Scientific Up 23.4% Since SmarTrend Uptrend Call (BSX)

SmarTrend identified an Uptrend for Boston Scientific (NYSE:BSX) on December 23rd, 2016 at $21.78. In approximately 5 months, Boston Scientific has returned 23.44% as of today's recent price of $26.89....

BSX : 27.32 (+0.22%)
SmarTrend Watching for Potential Pullback in Shares of Boston Scientific After 1.86% Gain

Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $26.39 to a high of $26.97. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of...

BSX : 27.32 (+0.22%)
Boston Scientific Set to Possibly Pullback After Yesterday's Rally of 1.86%

Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $26.39 to a high of $26.97. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of...

BSX : 27.32 (+0.22%)
Boston Scientific's Symetis Buyout Boosts Structural Heart

Boston Scientific Corporation (BSX) recently completed the acquisition of Switzerland-based Symetis SA.

HOLX : 43.35 (-0.34%)
EW : 114.25 (+0.07%)
BSX : 27.32 (+0.22%)
LMNX : 20.41 (-0.05%)
Boston Scientific Hits a 52-Week High on Solid Prospects

Share price of Natick, MA-based Boston Scientific Corporation (BSX) reached a new 52-week high of $26.76 on May 16, eventually closing a bit lower at $26.48.

HOLX : 43.35 (-0.34%)
EW : 114.25 (+0.07%)
BSX : 27.32 (+0.22%)
LMNX : 20.41 (-0.05%)
Boston Scientific to Participate in 2017 UBS Global Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2017 UBS Global Healthcare Conference on Tuesday, May 23, 2017 in New York City.

BSX : 27.32 (+0.22%)
Blog Coverage: Boston Scientific Completes Symetis Acquisition; Views TAVI Portfolio Expansion through the Agreement

Upcoming AWS Coverage on Hologic Post-Earnings Results

HOLX : 43.35 (-0.34%)
BSX : 27.32 (+0.22%)
Research and Markets - Global Urinary Slings Market to Grow at a CAGR of 10.12% by 2021 - Key Vendors are C. R. Bard, Boston Scientific, American Medical Systems & Coloplast

Research and Markets has announced the addition of the "Global Urinary Slings Market 2017-2021" report to their offering.

BSX : 27.32 (+0.22%)
Boston Scientific Announces Positive European Registry Results For WATCHMAN(TM) Left Atrial Appendage Closure Device

Boston Scientific (NYSE: BSX) today announced positive safety and efficacy rates of the WATCHMAN(TM) Left Atrial Appendage Closure (LAAC) Device from the EWOLUTION registry presented during a late-breaking...

BSX : 27.32 (+0.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary...

See More

Support & Resistance

2nd Resistance Point 27.67
1st Resistance Point 27.50
Last Price 27.32
1st Support Level 27.17
2nd Support Level 27.01

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.